Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004

Journal of the American Geriatrics Society

Volumn 56, Issue 3, 2008, Pages 484-492

  Suh, Dong Churl ^a   Kim, Chul Min ^a,b   Choi, In Sun ^a   Plauschinat, Craig A ^c  

^a RUTGERS UNIVERSITY   (United States)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Comorbid conditions; Diabetes mellitus; Elderly; Glycemic control

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; UNITED STATES;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; NUTRITION SURVEYS; PREVALENCE; TIME FACTORS;

EID: 40149087496     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01563.x     Document Type: Article

References (46)

1. Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population. Diabetes Care 2006 29 : 1263 1268.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003 26 : 917 932.
3. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 853.
4. Shetty S, Secnik K, Oglesby AK. Relationship of glycemic control to total diabetes-related costs for managed care plan members with type 2 diabetes. J Manag Care Pharm 2005 11 : 559 564.
5. Stephens JM, Botteman MF, Hay JW. Economic impact of antidiabetic medications and glycemic control on managed care organizations: A review of the literature. J Manag Care Pharm 2006 12 : 130 142.
6. Wagner EH, Sandhu N, Newton KM et al. Effect of improved glycemic control on health care costs and utilization. JAMA 2001 285 : 182 189.
7. Koro CE, Bowlin SJ, Bourgeois N et al. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report. Diabetes Care 2004 27 : 17 20.
8. Shorr RI, Ray WA, Daugherty JR et al. Incidence and risk factors for severe hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997 157 : 1681 1686.
9. Kaufman DW, Kelly JP, Rosenberg L et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002 287 : 337 344.
10. Turner RC, Cull CA, Frighi V et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). JAMA 1999 281 : 2005 2012.
11. Chaudhry SI, Berlowitz DR, Concato J. Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus? J Am Geriatr Soc 2005 53 : 1214 1216.
12. Centers for Disease Control and Prevention. NHANES 1999-2000 Public data release file documentation [on-line]. Available at Accessed March 1, 2006.
13. Centers for Disease Control and Prevention. NHANES 2001-2002 Public data release file documentation [on-line]. Available at Accessed March 1, 2006.
14. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 986.
15. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res 1998 6 (Suppl 2) : 51S 209S.
16. World Health Organization. Diet, Nutrition, and the Prevention of Chronic Disease. Geneva : World Health Organization, 1990.
17. American Diabetes Association. Standards of medical care in diabetes - 2007. Diabetes Care 2007 30 : S4 S41.
18. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994 89 : 1333 1345.
19. National Kidney Disease Education Program. MDRD equation [on-line]. Available at Accessed March 1, 2006.
20. Levey AS, Coresh J, Balk E. National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003 139 : 137 147.
21. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results form the national health and nutrition examination survey, 1999-2000. Circulation 2004 110 : 738 743.
22. Newman AB, Siscovick DS, Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation 1993 88 : 837 845.
23. Centers for Disease Control and Prevention. Analytic guidelines [on-line]. Available at Accessed March 1, 2006.
24. Korn EL, Graubard BI. Statistical Analysis with Survery Data: Analysis of Health Surveys. New York, NY : Wiley-Interscience Publications, 1999.
25. Allison P. Logistic Regression using the SAS System: Theory and Application. Cary, NC : SAS Institute, 1999.
26. Hosmer D, Lemeshow S. Applied Logistic Regression, 2nd Ed. New York, NY : John Wiley & Sons, 2000.
27. Munshi M, Grande L, Hayes M et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006 29 : 1794 1799.
28. Yaffe K, Blackwell T, Kanaya AM et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004 63 : 758 663.
29. De Renkeneire N, Resnick HE, Schwartz AV et al. Diabetes is associated with subclinical functional limitation in nondisabled older individuals: The health, aging, and body composition study. Diabetes Care 2003 26 : 3257 3263.
30. Bruce DG, Davis WA, Davis TM. Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 2005 28 : 2441 2447.
31. Rodriguez-Saldana J, Morley JE, Reynoso MT et al. Diabetes mellitus in a subgroup of older Mexicans: Prevalence, association with cardiovascular risk factors, functional and cognitive impairment, and mortality. J Am Geriatr Soc 2002 50 : 111 116.
32. Miller DK, Lui LY, Perry HM et al. Reported and measured physical functioning in older inner-city diabetic African Americans. J Gerontol A Biol Sci Med Sci 1999 54A : M230 M236.
33. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2006 29 : 1963 1972.
34. Glucophage (Metformin Hydrochloride) [Package Insert]. Princeton, NJ : Bristol-Myers Squibb Company, 2004.
35. Avandia (Rosiglitazone Maleate) [Package Insert]. Philadelphia, PA : GlaxoSmithKline Pharmaceuticals, 2000.
36. Actos (Pioglitazone Hydrochloride) [Package Insert]. Lincolnshire, IL : Takeda Pharmaceuticals America, 2000.
37. Kramer HJ, Nguyen QD, Curhan G et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003 289 : 3273 3277.
38. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis 1999 33 : 1004 1010.
39. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient? Diabetes 2000 49 : 1399 1408.
40. Venkat KK. Proteinuria and microalbuminuria in adults: Significance, evaluation, and treatment. South Med J 2004 97 : 969 979.
41. Parikh NA, Hwang SJ, Larson MG et al. Cardiovascular disease risk factors in chronic kidney disease: Overall burden and rates of treatment and control. Arch Intern Med 2006 166 : 1884 1891.
42. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 351 : 1296 1305.
43. Selvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the US. Diabetes Care 2006 29 : 2415 2419.
44. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1998 21 (Suppl 1) : S23 S31.
45. Stevens LA, Levey AS. Frequently asked Questions about GFR Estimates. New York, NY : National Kidney Foundation, 2004.
46. U.S. Census. The Elderly Population[on-line]. Available at Accessed December 12, 2006.